These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 710491)

  • 1. Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function.
    Wyss M; Diez C; Balavoine JF; Martin D; Bouvier CA
    Eur J Cardiol; 1978 Oct; 8(3):337-47. PubMed ID: 710491
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
    Harker LA; Slichter SJ
    N Engl J Med; 1970 Dec; 283(24):1302-5. PubMed ID: 5478451
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].
    Starkman C; Estampes B; Vernant P; Acar J
    Arch Mal Coeur Vaiss; 1982 Jan; 75(1):85-8. PubMed ID: 6803719
    [No Abstract]   [Full Text] [Related]  

  • 6. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current clinical results of antiplatelet medication].
    Ordinas A
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Persantine in preventing thromboembolism following valve replacement.
    Arrants JE; Hairston P
    Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombogenic therapy by use of antiplatelet agents with warfarin--its efficiency for the outpatients with prosthetic valve].
    Saitoh H
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Nov; 36(11):2396-407. PubMed ID: 3209894
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction in venous thromboembolism by agents affecting platelet function.
    Salzman EW; Harris WH; DeSanctis RW
    N Engl J Med; 1971 Jun; 284(23):1287-92. PubMed ID: 5576438
    [No Abstract]   [Full Text] [Related]  

  • 11. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thromboembolism prevention after heart valve prosthesis in an experimental model].
    Dragojevic D; Hetzer R; Corterier H
    Thoraxchir Vask Chir; 1972 Dec; 20(6):419-23. PubMed ID: 4539570
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombosis prevention and platelet functions following heart valve replacement].
    Aosaki M; Kitamura N
    Nihon Rinsho; 1978 Dec; 36(12):3874-83. PubMed ID: 372627
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves.
    Altman R; Boullon F; Rouvier J; Raca R; de la Fuente L; Favaloro R
    J Thorac Cardiovasc Surg; 1976 Jul; 72(1):127-9. PubMed ID: 1084448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
    Dale J; Myhre E; Rootwelt K
    Am Heart J; 1975 May; 89(5):613-8. PubMed ID: 1119369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.